Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
In the present era of coronavirus disease 2019 (COVID-19) pandemic, lack of an established and effective targeted therapy sans a vaccine is proving to be a major hurdle in containing the contagion. Hydroxychloroquine (HCQ), a widely used antimalarial and anti-inflammatory drug, has been proposed for...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Edice: | Journal of the Practice of Cardiovascular Sciences |
| Témata: | |
| On-line přístup: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2021;volume=7;issue=1;spage=78;epage=82;aulast=Kapoor |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|